Shimeng Pan
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- Glycosylation and Glycoproteins Research
- RNA Research and Splicing
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Extracellular vesicles in disease 2
- Circular RNAs in diseases 1
- RNA modifications and cancer 1
-
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 1
- Co-authors
- Yang Xiao (5 shared papers)Jia Li (5 shared papers)Bing Liu (5 shared papers)Shuangda Li (2 shared papers)Yiran Huang (2 shared papers)Qianqian Liu (2 shared papers)Yu Qi (2 shared papers)Huimin Zhou (3 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)European Journal of Cancer (1 paper)Clinica Chimica Acta (1 paper)
- Partner nations
- China
In The Last Decade
Shimeng Pan
6 papers receiving 349 citations
Peers
Comparison fields: 5 of 39
- Cancer Research 229
- Molecular Biology 284
- Immunology 29
- Oncology 27
- Biotechnology 7
Countries citing papers authored by Shimeng Pan
This map shows the geographic impact of Shimeng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shimeng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shimeng Pan more than expected).
Fields of papers citing papers by Shimeng Pan
This network shows the impact of papers produced by Shimeng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shimeng Pan. The network helps show where Shimeng Pan may publish in the future.
Co-authors
The 21 scholars most cited alongside Shimeng Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 122 | |
| 2 | 2019 | 69 | |
| 3 | 2019 | 64 | |
| 4 | 2018 | 49 | |
| 5 | 2019 | 46 | |
| 6 | 2011 | 1 |
About Shimeng Pan
Shimeng Pan is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Biotechnology, having authored 6 papers that have together received 351 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (2 papers), Cancer-related molecular mechanisms research (2 papers), Extracellular vesicles in disease (2 papers), Circular RNAs in diseases (1 paper), Cancer Research and Treatments (1 paper), MicroRNA in disease regulation (1 paper), Gastric Cancer Management and Outcomes (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (229 citations), Molecular Biology (284 citations), Immunology (29 citations), Oncology (27 citations) and Biotechnology (7 citations). Shimeng Pan has collaborated with scholars based in China. Frequent co-authors include Yang Xiao, Jia Li, Bing Liu, Shuangda Li, Yiran Huang, Qianqian Liu, Yu Qi, Huimin Zhou, Qianqian Liu and Jingchao Xu. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, European Journal of Cancer and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.